Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 3
1972 3
1973 1
1974 2
1975 4
1976 1
1978 2
1979 6
1980 8
1981 6
1982 7
1983 8
1984 5
1985 15
1986 14
1987 18
1988 15
1989 20
1990 20
1991 9
1992 19
1993 26
1994 17
1995 21
1996 23
1997 20
1998 31
1999 12
2000 25
2001 28
2002 31
2003 33
2004 31
2005 36
2006 56
2007 70
2008 73
2009 69
2010 93
2011 102
2012 117
2013 120
2014 107
2015 90
2016 109
2017 87
2018 114
2019 113
2020 138
2021 132
2022 109
2023 93
2024 35

Text availability

Article attribute

Article type

Publication date

Search Results

2,086 results

Results by year

Filters applied: . Clear all
Page 1
The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update.
Maurer M, Magerl M, Betschel S, Aberer W, Ansotegui IJ, Aygören-Pürsün E, Banerji A, Bara NA, Boccon-Gibod I, Bork K, Bouillet L, Boysen HB, Brodszki N, Busse PJ, Bygum A, Caballero T, Cancian M, Castaldo A, Cohn DM, Csuka D, Farkas H, Gompels M, Gower R, Grumach AS, Guidos-Fogelbach G, Hide M, Kang HR, Kaplan AP, Katelaris C, Kiani-Alikhan S, Lei WT, Lockey R, Longhurst H, Lumry WR, MacGinnitie A, Malbran A, Martinez Saguer I, Matta JJ, Nast A, Nguyen D, Nieto-Martinez SA, Pawankar R, Peter J, Porebski G, Prior N, Reshef A, Riedl M, Ritchie B, Rafique Sheikh F, Smith WB, Spaeth PJ, Stobiecki M, Toubi E, Varga LA, Weller K, Zanichelli A, Zhi Y, Zuraw B, Craig T. Maurer M, et al. Allergy. 2022 Jul;77(7):1961-1990. doi: 10.1111/all.15214. Epub 2022 Feb 3. Allergy. 2022. PMID: 35006617
The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of HAE with deficient C1 inhibitor (type 1) and HAE with dysfunctional C1 inhibitor (type 2), by providing guidance …
The goal of these recommendations and guideline is to help physicians and their patients in making rational decisions in the management of H …
Treatment of Hereditary Angioedema.
Caballero T. Caballero T. J Investig Allergol Clin Immunol. 2021 Feb;31(1):1-16. doi: 10.18176/jiaci.0653. J Investig Allergol Clin Immunol. 2021. PMID: 33602658 Free article. Review.
Hereditary angioedema due to C1-esterase inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease. ...Purified plasma-derived human C1 esterase inhibitor concentrate is the treatment of choice for short-term prophylaxis. ...
Hereditary angioedema due to C1-esterase inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease. ...Pur …
Hereditary Angioedema.
Wilkerson RG, Moellman JJ. Wilkerson RG, et al. Immunol Allergy Clin North Am. 2023 Aug;43(3):533-552. doi: 10.1016/j.iac.2022.10.012. Immunol Allergy Clin North Am. 2023. PMID: 37394258 Review.
Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder that usual results from a decreased level of functional C1-INH and clinically manifests with intermittent attacks of swelling of the subcutaneous tissue or submucosal layers of the respiratory or gas …
Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder that usual results from a decreased level of functional C1- …
Hereditary Angioedema.
Busse PJ, Christiansen SC. Busse PJ, et al. N Engl J Med. 2020 Mar 19;382(12):1136-1148. doi: 10.1056/NEJMra1808012. N Engl J Med. 2020. PMID: 32187470 Review. No abstract available.
Isolated angioedema: A review of classification and update on management.
Kesh S, Bernstein JA. Kesh S, et al. Ann Allergy Asthma Immunol. 2022 Dec;129(6):692-702. doi: 10.1016/j.anai.2022.08.003. Epub 2022 Aug 19. Ann Allergy Asthma Immunol. 2022. PMID: 35988876 Review.
RESULTS: Herein, a case-based approach is presented for discussing the major types of angioedema, including the following: hereditary angioedema types I and II and normal complement, acquired angioedema, angiotensin-converting enzyme-induced angioedema, and histaminergic a …
RESULTS: Herein, a case-based approach is presented for discussing the major types of angioedema, including the following: hereditary angioe …
Interventions for the long-term prevention of hereditary angioedema attacks.
Beard N, Frese M, Smertina E, Mere P, Katelaris C, Mills K. Beard N, et al. Cochrane Database Syst Rev. 2022 Nov 3;11(11):CD013403. doi: 10.1002/14651858.CD013403.pub2. Cochrane Database Syst Rev. 2022. PMID: 36326435 Free PMC article. Review.
People with Type I HAE (approximately 80% of all HAE cases) have insufficient amounts of C1 esterase inhibitor (C1-INH) protein; people with Type II HAE (approximately 20% of all cases) may have normal C1-INH concentrations, but, due to genetic …
People with Type I HAE (approximately 80% of all HAE cases) have insufficient amounts of C1 esterase inhibitor (C1-INH) …
C1, MBL-MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation.
Beinrohr L, Dobó J, Závodszky P, Gál P. Beinrohr L, et al. Trends Mol Med. 2008 Dec;14(12):511-21. doi: 10.1016/j.molmed.2008.09.009. Epub 2008 Nov 1. Trends Mol Med. 2008. PMID: 18977695 Review.
The associated proteases (C1r, C1s, MASP-1 and MASP-2) then activate the complement system. The serpin C1-inhibitor (C1-inh) blocks activity of all these complexes and has been successfully used in models of disease. ...Here, we propose an approach in …
The associated proteases (C1r, C1s, MASP-1 and MASP-2) then activate the complement system. The serpin C1-inhibitor ( …
Potential Roles for C1 Inhibitor in Transplantation.
Berger M, Baldwin WM 3rd, Jordan SC. Berger M, et al. Transplantation. 2016 Jul;100(7):1415-24. doi: 10.1097/TP.0000000000000995. Transplantation. 2016. PMID: 26599489 Free PMC article. Review.
The latter is increasingly recognized as a major cause of late graft loss, for which we have few effective therapies. C1 inhibitor (C1-INH) regulates several pathways which contribute to both acute and chronic graft injuries. ...Studies with C1-INH in …
The latter is increasingly recognized as a major cause of late graft loss, for which we have few effective therapies. C1 inhibitor …
Binding of human complement C1 sterase inhibitor to Leptospira spp.
Breda LCD, Vasconcellos SA, de Moraes Vasconcelos D, Isaac L. Breda LCD, et al. Immunobiology. 2018 Feb;223(2):183-190. doi: 10.1016/j.imbio.2017.10.027. Epub 2017 Oct 13. Immunobiology. 2018. PMID: 29107384
Pathogenic Leptospira interact with Complement Regulators such as Factor H, C4b binding protein and Vitronectin avoiding Complement activation and killing by Alternative and Classical Pathways. One important regulator is C1-inhibitor (C1INH) tha …
Pathogenic Leptospira interact with Complement Regulators such as Factor H, C4b binding protein and Vitronectin avoiding Co …
C1-inhibitor: more than a serine protease inhibitor.
Zeerleder S. Zeerleder S. Semin Thromb Hemost. 2011 Jun;37(4):362-74. doi: 10.1055/s-0031-1276585. Epub 2011 Jul 30. Semin Thromb Hemost. 2011. PMID: 21805442 Review.
C1-inhibitor (C1-inh) is a crucial regulator of the activation of plasmatic cascade systems involved in inflammation contributing to the homeostasis in the generation of proinflammatory mediators. ...Recent publications, however, suggest that the anti-inflamm …
C1-inhibitor (C1-inh) is a crucial regulator of the activation of plasmatic cascade systems involved in inflammation co …
2,086 results